(RTTNews) - Kairos Pharma, Ltd. (KAPA), a clinical-stage biopharmaceutical company, announced positive interim efficacy data from its ongoing Phase 2 clinical trial evaluating ENV-105 in combination with apalutamide in patients with metastatic castration-resistant prostate cancer
Fintel reports that on October 6, 2026, HSBC initiated coverage of Ermenegildo Zegna N.V. (NYSE:ZGN) (DB:JN0) with a Buy recommendation.Prior to this rating action, the company's stock closed at $12.54 on October 5, 2026. This latest close represents a one-week price change of -0
(RTTNews) - KBR Inc., (KBR), an engineering and technology company on Tuesday announced the award of an engineering contract by Saudi Arabian Oil Company (2222.sr) or Aramco, an energy and chemical company, to support operations across the Marjan offshore field in Arabian Gulf.
(RTTNews) - Telecom operator AT&T Inc. (T), announced on Tuesday that it has agreed to form a new U.S. fiber joint venture with Global Infrastructure Partners, a part of BlackRock, Inc. (BLK), and Canada Pension Plan Investment Board, to accelerate expansion of fiber internet acr
(RTTNews) - A report released by the Commerce Department on Tuesday showed the U.S. trade deficit widened by more than expected in the month of August.
(RTTNews) - Conexeu Sciences Inc. (CNXU) said it is advancing manufacturing scale-up, regulatory testing and preclinical work supporting a planned FDA 510(k) submission for Ten Minute Tissue, its lead wound care device candidate.
(RTTNews) - Tuesday, OpenTable and Visa Inc. (V) announced their decision to renew the agreement across the U.S., Mexico and Canada, planning to broaden the Visa Dining Collection in the regions and deliver an expanded events program.
(RTTNews) - Applied Materials, Inc. (AMAT), a materials engineering company, said on Tuesday that it is working with Intel Corporation (INTC) to boost development of chipmaking innovations for the next-generation transistors, interconnects, and advanced packaging technologies.
Fintel reports that on October 6, 2026, Guggenheim initiated coverage of LB Pharmaceuticals (NASDAQGM:LBRX) with a Buy recommendation. This coverage initiation follows other recent analyst actions for LB Pharmaceuticals. On October 5, 2026, Roth Capital downgraded the company fro
(RTTNews) - 60 Degrees Pharmaceuticals (SXTP) said it plans to unblind its study of tafenoquine in hospitalised patients with severe babesiosis in January 2027 and will request a pre-supplemental New Drug Application (sNDA) meeting with the FDA that same month following a schedul
(RTTNews) - HeartSciences Inc. (HSCS), a healthcare technology company, said the FDA has granted 510(k) clearance for its MyoVista wavECG device. The company had submitted the device for 510(k) review in December 2025.
(RTTNews) - Google, part of Alphabet Inc. (GOOG), and Constellation Energy Corp. (CEG), a utilities company, on Tuesday announced power agreements to supply around 3,600 megawatts or MW onto the PJM Interconnection grid, aiming to meet growing demand.
Key PointsThe average Social Security beneficiary in their 60s received about $1,878 in December 2025, while the average beneficiary in their 70s received $2,194.
(RTTNews) - The U.K. communications regulator Ofcom said Tuesday it has opened an investigation into whether Meta Platforms (META) failed to comply with its Online Safety Act duties before launching Instagram Instants.